PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study

Por Woo, Young Sup, Park, Joo Eon, Kim, Do-Hoon, Sohn, Inki, Hwang, Tae-Yeon, Park, Young-Min, Jon, Duk-In, Jeong, Jong-Hyun, Bahk, Won-Myong, Woo, Y. S., Jeong, J. H., Bahk, W. M., Sohn, I. K., Park, J. E., Kim, D. H., Hwang, T. Y., Park, Y. M., Jon, D. I.
Publicado no Int J Neuropsychopharmacol (2016)